Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-24

FDA Approved: MICAFUNGIN — Original Application (Northstar Rx LLC.)

View source ↗

Summary

FDA approved Northstar Rx LLC's original application for micafungin, a generic antifungal, for the treatment of invasive candidiasis including candidemia and es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN)